KRAZATI Trademark

Trademark Overview


On Thursday, March 25, 2021, a trademark application was filed for KRAZATI with the United States Patent and Trademark Office. The USPTO has given the KRAZATI trademark a serial number of 90603915. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Mirati Therapeutics, Inc.. The KRAZATI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the ...

research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
krazati

General Information


Serial Number90603915
Word MarkKRAZATI
Filing DateThursday, March 25, 2021
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7019779
Registration DateTuesday, April 4, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
Goods and Servicesresearch and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateTuesday, December 13, 2022
First Use In Commerce DateTuesday, December 13, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code042
First Use Anywhere DateTuesday, December 13, 2022
First Use In Commerce DateTuesday, December 13, 2022

Trademark Owner History


Party NameMirati Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirati Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirati Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, March 29, 2021NEW APPLICATION ENTERED
Wednesday, June 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021ASSIGNED TO EXAMINER
Monday, November 8, 2021NON-FINAL ACTION WRITTEN
Monday, November 8, 2021NON-FINAL ACTION E-MAILED
Monday, November 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 9, 2021ASSIGNED TO LIE
Monday, December 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 15, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, January 15, 2022EXAMINERS AMENDMENT E-MAILED
Saturday, January 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 15, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 1 FILED
Monday, October 17, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 2, 2023TEAS STATEMENT OF USE RECEIVED
Monday, January 2, 2023USE AMENDMENT FILED
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 1, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, February 27, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 28, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER